RxDoctor Payments Data

Brian Lima, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Nashville, TNNPI 1669649703

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.2%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Abiomed at 45.5% of the total. Reporting peaked in 2022 at $10,876 and has fallen 97.2% since, to $306 in 2025.

$18,113in general payments, 2019–2025

Across 132 payments — averaging $137.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$8K
  • Paragonix Technologies, Inc.$4K
  • Abbott$3K
  • Medtronic$1K
  • Atricure, Inc.$898
  • Getinge USA Sales, LLC$427
  • plus $1K from 17 others
$468,782in research payments, 2019–2025

Across 29 payments — averaging $16,165 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$469K

What the payments were for

  • Consulting fees$5003%
  • Speaking & faculty fees$7,75043%
  • Travel & lodging$5803%
  • Food & beverage$9,28251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,113 in reported general payments places this provider in the 80th percentile of 115 thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Tennessee

Medicare billing

Part B allowed, 2024
$101,096
Medicare patients
155
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →